File: b-be-08-bvw1-public-information-from-the-notifier.pdfTrial reference: MI-CP178: Study of a Live, Attenuated Intranasal Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to < 24 Month-Old Children and in 2 Month-Old InfantsDoc type: Information for the public
